BRIDGEWATER, NJ--(Marketwire - October 29, 2007) - Alpharma Inc. (NYSE: ALO), a global specialty pharmaceutical company, announced third quarter 2007 diluted earnings per share (“EPS”) of $0.34, versus EPS of $0.31 in the third quarter of 2006. Revenue of $175.8 million in the third quarter of 2007 increased 6.4% versus the third quarter of 2006, driven principally by gains in the company’s Pharmaceuticals business. Operating income in the third quarter of 2007 was $19.7 million, a decrease of $2.5 million compared to last year’s third quarter, reflecting $6.5 million of increased research and development (“R&D”) spending, primarily related to the company’s abuse-deterrent pain product platform in its Pharmaceuticals business.
